当前位置:主页 > 医学论文 > 药学论文 >

药品医保支付价格形成机制的国际经验及启示

发布时间:2018-06-17 02:05

  本文选题:药品价格 + 价格形成机制 ; 参考:《中国药房》2017年24期


【摘要】:目的:为我国制定合理的药品医保支付价格提供借鉴。方法:通过检索分析国内外正式发表的学术文章、官方网站和政府文件、新闻报道等资料和知情人访谈,总结国际主要药品医保支付价格形成机制,高值药可持续的公平可及的解决方式,为我国制定合理的药品价格政策提出建议。结果与结论:国际通用的医药支付价格的确定依据为内部参考定价法、增量成本-效果评价法、外部参考定价法。国际社会还采取以公平药价计划、药品专利池、开源药物研发组织等形式促进高值药可持续地公平可及。我国实现全民医保目标后,应积极探索制定合理的医保支付价格。可以在仿制药质量和临床疗效一致性评价后,采用内部参考定价法确定有仿制药竞争品种的支付标准,采用外部参考定价法或增量成本-效果评价法确定创新专利药品价格谈判的参考价格,对高值药物采用公平定价的理念。
[Abstract]:Objective: to provide reference for the establishment of reasonable medical insurance payment price in China. Methods: through the retrieval and analysis of published academic articles, official websites and government documents, news reports and interviews with insiders, the formation mechanism of international major drug insurance payment price was summarized. Sustainable, fair and accessible solutions for high-value drugs are proposed for the formulation of reasonable drug price policies in China. Results & conclusion: the international general pricing of pharmaceutical payment is based on internal reference pricing, incremental cost-effect evaluation and external reference pricing. The international community also promotes sustainable and equitable access to high-value drugs in the form of fair drug pricing schemes, drug patent pools, and open source drug research and development organizations. After our country realizes the goal of universal medical insurance, we should actively explore the reasonable medical insurance payment price. After evaluating the consistency between the quality and clinical efficacy of generic drugs, the internal reference pricing method can be used to determine the payment criteria for competing varieties of generic drugs. The external reference pricing method or incremental cost-effect evaluation method is used to determine the reference price of the innovative patent drug price negotiation, and the fair pricing concept for high value drugs is adopted.
【作者单位】: 中国医学科学院北京协和医学院公共卫生学院;
【基金】:中央级公益性科研院所基本科研业务费项目 国家卫生计生委药政司委托研究课题(No.药政[2016]9号)
【分类号】:R951


本文编号:2029123

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2029123.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户9b62f***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com